Vbi Vaccines Inc CS (VBIV)

As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.

VBI Vaccines News: VBIV Stock Skyrockets 17% on Clinical Trial Success

By William White, InvestorPlace Writer Jan 13, 2020

VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.

5 Stocks to Buy Based on Insider Buying

By Mark Putrino, CMT Oct 8, 2019

These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.

3 Pivotal Drug Trials to Watch for Explosive Potential

By Samuel Rae, InvestorPlace Contributor Jun 29, 2017

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.

Earnings Preview: VBI Vaccines, Inc. (VBIV) Q2 Earnings Expected to Decline

From Zacks Investment Research Jul 23, 2021

VBI Vaccines, Inc. (VBIV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Shares of VBI Vaccines Soared, and Then Fell 7%, on Tuesday

From The Motley Fool Jun 29, 2021

Investors almost seemed ready to take profits once shares hit their highest level since February.

VBI Vaccines Stock Is Trading Higher On Encouraging Data From COVID-19 Vaccine Candidate Trial

From Benzinga Jun 29, 2021

VBI Vaccines Inc (NASDAQ: VBIV) has announced positive Phase 1 data from its Phase 1/2 trial evaluating its enveloped virus-like particle (eVLP) COVID-19 vaccine...

Why Agenus Stock Is Jumping Today

From The Motley Fool Jun 8, 2021

There was some positive news, but it probably wasn't a huge catalyst for the stock.

VBI Vaccines' Brain Cancer Immunotherapy Gets FDA Fast Track Review; Announces Updated Tumor Response, Overall Survival Data

From Benzinga Jun 8, 2021

The FDA has granted Fast Track Designation for VBI Vaccines Inc's (NASDAQ: VBIV) VBI-1901, its cancer vaccine immunotherapeutic candidate to treat...

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

From Benzinga May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Vbi Vaccines Inc CS (VBIV)

7 Penny Stocks Waiting on the FDA for Rocket Fuel

8 Biotech Penny Stocks for Investors to Watch

8 Penny Stocks to Avoid in 2021

7 Short-Term Stocks to Make a Quick Buck

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Vbi Vaccines Inc CS (VBIV)

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

Subscriber Sign in